一个MYC控制的氧化还原开关保护B淋巴瘤细胞免受EGR1-依赖的亡
Haidong Yao1, Xue Chen2, Ting Wang1
1Department of Biosciences and Nutrition, Karolinska Institutet, 141 83 Huddinge, Sweden.
Cell reports
|August 10, 2023
概括
高MYC表达驱动淋巴瘤. N-乙半氨酸 (NAC) 和维生素C (VitC) 减少氧化应激,诱导MYC驱动的淋巴瘤细胞的亡,提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 耐药性和复发性B细胞淋巴瘤是由MYC瘤基因驱动的.
- 在正常的氧化应激下,MYC促进了淋巴瘤细胞的增殖,并抑制了亡.
- 在淋巴瘤中准MYC仍然是一个重大的临床挑战.
研究的目的:
- 调查氧化应激在MYC驱动淋巴瘤中的作用.
- 探索N-乙半氨酸 (NAC) 和维生素C (VitC) 在MYC驱动的B细胞淋巴瘤中的治疗潜力.
- 阐明NAC和VitC影响MYC功能的分子机制.
主要方法:
- 评估MYC表达对淋巴瘤细胞增殖和亡的影响.
- 评估NAC和VitC在减少瘤生长中的有效性,在体外和体内.
- 研究MYC淘汰和激活对细胞对NAC和VitC反应的影响.
- 在NAC和VitC治疗后分析MYC,EGR1和基因表达变化之间的相互作用.
主要成果:
- 高MYC表达增强了淋巴瘤细胞的增殖和生存,通过保护细胞灭亡.
- NAC和VitC治疗可以减少氧化应激,诱导亡并抑制MYC高的淋巴瘤细胞中的瘤生长.
- 通过MYC的淘汰,对NAC和VitC产生抗性,而MYC的激活会增加灵敏度.
- NAC和VitC促进MYC与EGR1的结合,将基因表达从细胞周期促进转移到细胞亡诱导.
结论:
- 在B细胞淋巴瘤中MYC的致癌功能与增殖和亡的氧化还原控制有关.
- 在MYC驱动的淋巴瘤中,NAC和VitC通过准MYC-EGR1轴来证明治疗潜力.
- 这些发现表明,在MYC驱动的B细胞淋巴瘤患者中,使用NAC或VitC是一种潜在的临床策略.
更多相关视频
10:26In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
12.3K
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
6.2K
相关概念视频
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
